BioSyent (RX) Insider Trading & Ownership C$10.95 +0.15 (+1.39%) As of 05/2/2025 03:43 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock BioSyent (CVE:RX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.65%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)C$9.00 M Get RX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioSyent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RX Insider Buying and Selling by Quarter BioSyent Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2025Peter Douglas LockhardDirectorSell40C$11.25C$450.003/18/2025Peter Douglas LockhardDirectorSell100C$11.25C$1,125.0012/23/2024FAX Capital Corp.InsiderSell112,400C$11.28C$1,267,557.2812/16/2024Seyed Ahmad AshrafiDirectorSell532C$12.02C$6,394.6412/12/2024Robert Joseph MarchSenior OfficerSell4,775C$11.65C$55,628.7511/25/2024Peter Douglas LockhardDirectorSell637C$11.45C$7,293.6511/22/2024FAX Capital Corp.InsiderSell230,800C$11.12C$2,566,496.009/23/2024Peter Douglas LockhardDirectorSell600C$11.10C$6,660.009/20/2024Seyed Ahmad AshrafiDirectorSell2,320C$10.95C$25,404.007/23/2024FAX Capital Corp.InsiderSell500,000C$10.05C$5,025,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/28/2024Sharan RaghubirSenior OfficerSell423C$10.04C$4,246.926/20/2024Sharan RaghubirSenior OfficerSell1,755C$10.01C$17,566.506/12/2024Rene GoehrumDirectorSell1,522C$9.38C$14,276.365/22/2024Peter Douglas LockhardDirectorSell432C$8.95C$3,866.40 (Data available from 1/1/2013 forward) RX Insider Trading Activity - Frequently Asked Questions Who is on BioSyent's Insider Roster? The list of insiders at BioSyent includes BioSyent Inc., Blair Driscoll, FAX Capital Corp., Larry Andrews, Peter Douglas Lockhard, Rene Goehrum, Robert Joseph March, Seyed Ahmad Ashrafi, and Sharan Raghubir. Learn more on insiders at RX. What percentage of BioSyent stock is owned by insiders? 33.65% of BioSyent stock is owned by insiders. Learn more on RX's insider holdings. Which BioSyent insiders have been buying company stock? The following insiders have purchased RX shares in the last 24 months: BioSyent Inc. (C$43,627.95), and Larry Andrews (C$8,700.00). How much insider buying is happening at BioSyent? Insiders have purchased a total of 6,100 RX shares in the last 24 months for a total of C$52,327.95 bought. Which BioSyent insiders have been selling company stock? The following insiders have sold RX shares in the last 24 months: FAX Capital Corp. (C$8,859,053.28), Peter Douglas Lockhard (C$24,615.05), Rene Goehrum (C$14,276.36), Robert Joseph March (C$55,628.75), Seyed Ahmad Ashrafi (C$40,298.64), and Sharan Raghubir (C$21,813.42). How much insider selling is happening at BioSyent? Insiders have sold a total of 857,936 BioSyent shares in the last 24 months for a total of C$9,015,685.50 sold. BioSyent Key ExecutivesMr. René C. Goehrum (Age 65)Chairman, CEO & President Compensation: $594.99kMr. Robert J. MarchVP of Finance & CFOMr. Joost van der MarkVice President of Corporate DevelopmentMs. Neelu AtwalDirector of Human Resources More Insider Trading Tools from MarketBeat Related Companies Aurora Cannabis Insider Trades Canopy Growth Insider Trades Cipher Pharmaceuticals Insider Trades Organigram Insider Trades Cardiol Therapeutics Insider Trades HLS Therapeutics Insider Trades Medexus Pharmaceuticals Insider Trades Decibel Cannabis Insider Trades Crescita Therapeutics Insider Trades Indiva Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (CVE:RX) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RX Stock Free RX Stock Alerts